Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank S Ghantoji

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Archives of Internal Medicine|October 12, 2011
Novel intervention for eliminating VRE from the environmentRoy F Chemaly, Shashank S Ghantoji, Mark Stibich
Infection Control and Hospital Epidemiology|September 3, 2015
Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital SettingRoy F Chemaly, Shashank S Ghantoji, Thomas Huber, et al.
American Journal of Blood Research|December 11, 2012
Management of respiratory viral infections in hematopoietic cell transplant recipientsDimpy P Shah, Shashank S Ghantoji, Victor E Mulanovich, et al.
Journal of Medical Microbiology|January 29, 2015
Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation roomsShashank S Ghantoji, Mark Stibich, Julie Stachowiak, et al.
Therapeutic Advances in Infectious Disease|December 4, 2014
The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containmentRoy F Chemaly, Sarah Simmons, Charles Dale, et al.
Pharmacotherapy|August 29, 2014
The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancerAmin Esmaily-Fard, Frank P Tverdek, David M Crowther, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2011
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infectionKevin W Garey, Shashank S Ghantoji, Dhara N Shah, et al.
BMC Infectious Diseases|October 12, 2017
Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating roomsLynn El Haddad, Shashank S Ghantoji, Mark Stibich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2021
Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital RoomsLynn El Haddad, Blake M Hanson, Cesar A Arias, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2015
Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipientsSamuel L Aitken, Jian Zhou, Shashank S Ghantoji, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Archives of Internal Medicine|October 12, 2011
Novel intervention for eliminating VRE from the environmentRoy F Chemaly, Shashank S Ghantoji, Mark Stibich
Infection Control and Hospital Epidemiology|September 3, 2015
Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital SettingRoy F Chemaly, Shashank S Ghantoji, Thomas Huber, et al.
American Journal of Blood Research|December 11, 2012
Management of respiratory viral infections in hematopoietic cell transplant recipientsDimpy P Shah, Shashank S Ghantoji, Victor E Mulanovich, et al.
Journal of Medical Microbiology|January 29, 2015
Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation roomsShashank S Ghantoji, Mark Stibich, Julie Stachowiak, et al.
Therapeutic Advances in Infectious Disease|December 4, 2014
The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containmentRoy F Chemaly, Sarah Simmons, Charles Dale, et al.
Pharmacotherapy|August 29, 2014
The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancerAmin Esmaily-Fard, Frank P Tverdek, David M Crowther, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2011
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infectionKevin W Garey, Shashank S Ghantoji, Dhara N Shah, et al.
BMC Infectious Diseases|October 12, 2017
Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating roomsLynn El Haddad, Shashank S Ghantoji, Mark Stibich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2021
Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital RoomsLynn El Haddad, Blake M Hanson, Cesar A Arias, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2015
Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipientsSamuel L Aitken, Jian Zhou, Shashank S Ghantoji, et al.
Pageof 3